Nci 8511: Phase I/Ii Study Of Cetuximab With R04929097 In Colon Cancer
Nci 8511: Phase I/Ii Study Of Cetuximab With R04929097 In Colon Cancer | |
|---|---|
| Sponsor(s) | H. Lee Moffitt Cancer Center and Research Institute |
| Principal Investigator(s) | John Kauh, MD |
| Dates | 8/10/2010 - 8/05/2013 |
